Administrative Simplification: Change to the Compliance Date for the International Classification of Diseases, 10th Revision (ICD-10-CM and ICD-10-PCS) Medical Data Code Sets, 45128-45134 [2014-18347]
Download as PDF
45128
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Rules and Regulations
State
City/town/county
City of Newport News
Source of flooding
*Elevation in feet
(NGVD)
+Elevation in feet
(NAVD)
#Depth in feet
above ground
∧Elevation in
meters (MSL)
Modified
Location
Approximately 776 feet downstream of
Richneck Road.
Approximately 1,450 feet upstream of Windsor
Castle Drive.
Just downstream of Richneck Road ................
Stoney Run-Denbigh
Branch.
+40
Just downstream of McManus Boulevard ........
City of Newport News
Stoney Run-Colony
Pines Branch.
+27
+33
+27
* National Geodetic Vertical Datum.
+ North American Vertical Datum.
# Depth in feet above ground.
∧ Mean Sea Level, rounded to the nearest 0.1 meter.
ADDRESSES
City of Newport News
Maps are available for inspection at the Department of Engineering, 2400 Washington Avenue, Newport News, VA 23607.
(Catalog of Federal Domestic Assistance No.
97.022, ‘‘Flood Insurance.’’)
Dated: July 11, 2014.
Roy E. Wright,
Deputy Associate Administrator for
Mitigation, Department of Homeland
Security, Federal Emergency Management
Agency.
[FR Doc. 2014–18364 Filed 8–1–14; 8:45 am]
BILLING CODE 9110–12–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
45 CFR Part 162
hospital procedure coding, including
the Official ICD–10–PCS Guidelines for
Coding and Reporting, from October 1,
2014 to October 1, 2015. It also requires
the continued use of the International
Classification of Diseases, 9th Revision,
Clinical Modification, Volumes 1 and 2
(diagnoses), and 3 (procedures) (ICD–9–
CM), including the Official ICD–9–CM
Guidelines for Coding and Reporting,
through September 30, 2015.
DATES: These regulations are effective
on September 3, 2014.
FOR FURTHER INFORMATION CONTACT:
Denesecia Green, (410) 786–8797.
Geanelle G. Herring, (410) 786–4466.
Kamahanahokulani Farrar, (410) 786–
2155.
[CMS–0043–F]
SUPPLEMENTARY INFORMATION:
RIN 0938–AS31
I. Executive Summary and Background
Administrative Simplification: Change
to the Compliance Date for the
International Classification of
Diseases, 10th Revision (ICD–10–CM
and ICD–10–PCS) Medical Data Code
Sets
A. Executive Summary
Office of the Secretary, HHS.
ACTION: Final rule.
AGENCY:
This final rule implements
section 212 of the Protecting Access to
Medicare Act of 2014 by changing the
compliance date for the International
Classification of Diseases, 10th
Revision, Clinical Modification (ICD–
10–CM) for diagnosis coding, including
the Official ICD–10–CM Guidelines for
Coding and Reporting, and the
International Classification of Diseases,
10th Revision, Procedure Coding
System (ICD–10–PCS) for inpatient
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:31 Aug 01, 2014
Jkt 232001
1. Purpose
Prior to the enactment of the
Protecting Access to Medicare Act of
2014 (PAMA) (Pub. L. 113–93) on April
1, 2014, the health care industry was
actively preparing to transition to the
International Classification of Diseases,
10th Revision, Clinical Modification
(ICD–10–CM) for diagnosis coding and
the International Classification of
Diseases, 10th Revision, Procedure
Coding System (ICD–10–PCS) for
inpatient hospital procedure coding
(herein collectively referred to as ICD–
10) on October 1, 2014. Many in the
health care industry had invested time
and resources in system upgrades,
testing, training, and undertaking the
necessary changes to workflow
processes. However, PAMA required the
PO 00000
Frm 00044
Fmt 4700
Sfmt 4700
Secretary to adopt ICD–10 no sooner
than October 1, 2015.
This final rule establishes October 1,
2015, as the new ICD–10 compliance
date. This final rule also requires the
continued use of the International
Classification of Diseases, 9th Revision,
Clinical Modification, Volumes 1 and 2
(diagnoses), and 3 (procedures),
including the Official ICD–9–CM
Guidelines for Coding and Reporting
(herein collectively referred to as ICD–
9–CM), through September 30, 2015.
a. Need for the Regulatory Action
This final rule establishes October 1,
2015 as the compliance date for ICD–10.
It also requires the continued use of
ICD–9–CM through September 30, 2015.
b. Legal Authority for the Regulatory
Action
Section 212 of PAMA, titled ‘‘Delay in
Transition from ICD–9–CM to ICD–10
Code Sets’’ is the legal authority for the
regulatory action.
2. Summary of the Major Provisions
As noted previously, this final rule
changes the compliance date for ICD–10
from October 1, 2014 to October 1, 2015
and requires covered entities to
continue using ICD–9–CM through
September 30, 2015.
3. Summary of Costs and Benefits
In the September 5, 2012 Federal
Register (77 FR 54664), the Department
of Health and Human Services (HHS)
published a final rule titled
‘‘Administrative Simplification:
Adoption of a Standard for a Unique
Health Plan Identifier; Addition to the
National Provider Identifier
E:\FR\FM\04AUR1.SGM
04AUR1
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with NOTICES
Requirements; and a Change to the
Compliance Date for the International
Classification of Diseases, 10th Edition
(ICD–10–CM and ICD–10–PCS) Medical
Data Code Sets’’ (herein referred to as
the 2012 ICD–10 Delay final rule) in
which the Secretary changed the
compliance date for ICD–10 from
October 1, 2013 to October 1, 2014. In
that rule, we estimated there would be
a significant cost to industry from a
delay of ICD–10 because commercial
health plans, medium and large
hospitals, and large physician practices
were far along in their implementation
and had devoted funds, resources, and
staff to the effort. In our analysis, we
estimated that a 1-year delay of the
compliance date for ICD–10 would add
a range of 10 to 30 percent to the total
cost that these entities had already spent
or budgeted for the transition to ICD–10
on October 1, 2013.
We use the same rationale and
methodology in our analysis of costs
and benefits in the Regulatory Impact
Analysis (RIA) of this final rule, and
conclude that a delay of 1-year, as
opposed to a longer delay, will be the
least costly and most fiscally
responsible way to implement the
requirements of section 212 of PAMA.
We estimate the cost of a 1-year delay
to HIPAA covered entities will be $1.1
to $6.8 billion.
B. Background
In the January 16, 2009 Federal
Register (74 FR 3328), HHS published a
final rule (herein referred to as the 2009
ICD–10 final rule) in which the
Secretary adopted ICD–10 as the Health
Insurance Portability and
Accountability Act of 1996 (HIPAA)
standard code set to replace ICD–9–CM.
The 2009 ICD–10 final rule established
an October 1, 2013 compliance date for
ICD–10. For more background on the
adoption of ICD–10, see the 2009 ICD–
10 final rule and the August 22, 2008
proposed rule titled ‘‘HIPAA
Administrative Simplification:
Modification to Medical Data Code Set
Standards to Adopt ICD–10–CM and
ICD–10–PCS’’ (herein referred to as the
2008 ICD–10 proposed rule) (73 FR
49796).
In late 2011 and early 2012, three
issues emerged that led the Secretary to
reconsider the compliance date for ICD–
10: (1) The industry transition to ASC
X12 Version 5010 did not proceed as
effectively as expected; (2) providers
became concerned that other statutory
initiatives were stretching their
resources; and (3) there was a lack of
readiness for the ICD–10 transition, as
indicated by industry surveys and polls.
As a result, HHS published the 2012
VerDate Mar<15>2010
16:31 Aug 01, 2014
Jkt 232001
ICD–10 Delay final rule in which the
compliance date for ICD–10 was
delayed from October 1, 2013 to October
1, 2014.
II. Provisions of the Final Rule
Section 212 of PAMA provides that
the Secretary may not adopt ICD–10
under HIPAA prior to October 1, 2015.
We interpret this provision as requiring
the Secretary to delay the October 1,
2014 implementation of ICD–10, and we
believe the provision gives the Secretary
discretion to choose a new compliance
date of October 1, 2015, or later. We are
establishing October 1, 2015 as the new
compliance date.
All segments of the health care
industry have invested significant time
and resources in financing, training, and
implementing necessary changes to
systems, workflow processes, and
clinical documentation practices in
order to prepare for ICD–10. The
American Academy of Professional
Coders (AAPC) provides training and
education to medical coders, physicians
and their practice management staff. In
a June 2014 survey 1 of 5,000 AAPC
members, nearly 75 percent of the
survey respondents reported that they
are making significant progress toward
preparing for ICD–10 implementation.
The survey also indicated that about 25
percent of those surveyed had
completed all of the necessary ICD–10
training; 13 percent indicated that they
were prepared for the October 1, 2014
implementation date; and 23 percent
were actively testing with their ICD–10
vendors when PAMA was signed into
law. The industry has made significant
progress toward ICD–10 compliance and
has gained momentum in its efforts. A
delay of longer than 1 year would slow
or even stop progress towards ICD–10
implementation. In order to preserve
this momentum and encourage
continued compliance efforts, we are
establishing the shortest delay permitted
by law, which is 1 year.
Additionally, we believe it is
important to require implementation of
ICD–10 as soon as the law permits
because it will allow the industry to
begin reaping the benefits of ICD–10 as
soon as possible. ICD–10 provides
greater specificity of diagnosis-related
groups; improves quality measurement
and reporting capabilities; improves
tracking of illnesses; and reflects greater
accuracy of reimbursement for medical
services. ICD–10’s granularity will
1 ICD–10 Monitor: Exclusive: ICD–10
Implementation—Where Do We Really Stand?
https://icd10monitor.com/enews/item/1220exclusive-icd-10-implementation-where-do-wereally-stand?utm_source=Real%20Magnet&utm_
medium=Email&utm_campaign=42358626.
PO 00000
Frm 00045
Fmt 4700
Sfmt 4700
45129
improve data capture and analytics of
public health surveillance and
reporting, national quality reporting,
research and data analysis, and provide
detailed data to inform health care
delivery and health policy decisions.
ICD–10 reflects the advances in
medicine and medical technology that
U.S. physician specialty groups called
for as they provided extensive input
into the development of the ICD–10–CM
code-set to capture more precise codes
for the conditions they treat. ICD–10
includes significant improvements over
ICD–9–CM in coding primary care
encounters, external causes of injury,
mental disorders, and preventive health.
For example, ICD–10 reflects improved
diagnosis of chronic illness and
identifies underlying causes,
complications of disease, and
conditions that contribute to the
complexity of a disease, and captures
the severity and stage of diseases such
as chronic kidney disease, dementia,
and asthma.
Finally, a 1-year delay, as opposed to
a longer delay, is the least expensive
option for the industry. As estimated in
the 2012 ICD–10 Delay final rule 2 and
repeated in this final rule, a 1-year delay
increases costs for covered entities by a
range of 10 to 30 percent. We conclude
that a delay beyond 1 year would be
significantly more costly and have a
damaging impact on the healthcare
industry. For example, extending the
delay beyond 1 year could render
current ICD–10 system updates and
releases obsolete, which would
diminish the investments stakeholders
have already made to prepare for the
ICD–10 transition. Stakeholders would
need to restart their system preparation
and would not be able to leverage past
system investments.
In order to implement section 212 of
PAMA, we are changing the compliance
date for ICD–10 from October 1, 2014 to
October 1, 2015 in 45 CFR 162.1002(c)
by changing ‘‘October 1, 2014’’ to
‘‘October 1, 2015’’ to read, ‘‘[f]or the
period on and after October 1, 2015.’’
Our regulations at 45 CFR 162.1002(b)
currently require compliance with ICD–
9–CM through September 30, 2014. We
are changing our regulations to require
the continued use of ICD–9–CM through
September 30, 2015. Accordingly, we
are revising 45 CFR 162.1002(b) by
2 Administrative Simplification: Adoption of a
Standard for a Unique Health Plan Identifier;
Addition to the National Provider Identifier
Requirements; and a Change to the Compliance
Date for the International Classification of Diseases,
10th Edition (ICD–10–CM and ICD–10–PCS)
Medical Data Code Sets; Final Rule. https://www.
gpo.gov/fdsys/pkg/FR-2012-09-05/pdf/201221238.pdf pages 50–53.
E:\FR\FM\04AUR1.SGM
04AUR1
45130
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Rules and Regulations
mstockstill on DSK4VPTVN1PROD with NOTICES
changing ‘‘September 30, 2014’’ to
‘‘September 30, 2015’’ to read, ‘‘[f]or the
period on and after October 16, 2003
through September 30, 2015.’’
III. Waiver of Proposed Rulemaking
Under 5 U.S.C. 553(b) of the
Administrative Procedure Act (APA),
we are required to publish a notice of
proposed rulemaking (NPRM) in the
Federal Register. Section 553(b) of the
APA provides an exception to this
requirement. Section 553(b)(B) of the
APA authorizes HHS to waive normal
rulemaking requirements if it finds that
notice and comment procedures are
impracticable, unnecessary, or contrary
to the public interest. We believe
waiving normal notice and comment
rulemaking requirements is justified
because covered entities need to know
how to proceed with respect to ICD–9–
CM and ICD–10 now, or they will not
have adequate time to prepare to
accurately submit, process, and pay for
health care claims.
The October 1, 2014 compliance date
for ICD–10 was established in the 2012
ICD–10 Delay final rule. Section 212 of
PAMA was enacted on April 1, 2014, six
months prior to the October 1, 2014
ICD–10 compliance date, at a critical
time when most health care entities had
already configured and tested systems
and business processes, and devoted
staff and financial resources in
preparation for compliance on October
1, 2014. IT systems were changed to
align with new payment policies and
rules, staff was trained on new
workflow processes, and trading partner
agreements were updated to begin using
ICD–10 on October 1, 2014.
After section 212 of PAMA was
enacted, many industry stakeholders
asked the Secretary to clarify which ICD
version could or must be used and
when. Many interpreted section 212 of
PAMA as requiring a delay of ICD–10 to
October 1, 2015, while others
interpreted the law as allowing the
Secretary to postpone implementation
of ICD–10 for longer than a year. Other
industry stakeholders suggested that
section 212 of PAMA permitted covered
entities to use either ICD–9–CM or ICD–
10 on October 1, 2014. These widely
different interpretations reflected the
industry’s uncertainty about when it
would be required to use specific
versions of the ICD coding system, and
we recognized a growing apprehension
among stakeholders in light of this
uncertainty.
There are also a number of important
business and implementation decisions
that industry stakeholders have to make
now. For example, budgeting, project
management, and systems planning for
VerDate Mar<15>2010
16:31 Aug 01, 2014
Jkt 232001
the continued use of ICD–9–CM on
October 1, 2014 and for the delayed
implementation of ICD–10 on October 1,
2015, must begin as soon as possible for
all covered entities. Both large and
small providers and health plans
generally develop budgets and allot
resources for transitions far in advance
and particularly for those transitions
that impact IT systems, business
policies, and processes. Most covered
entities have allocated funds, assigned
human resources, and have employed
contractors to assist with or manage
various aspects of the transition to ICD–
10 based on an October 1, 2014
compliance date. These resources,
trading partner agreements, vendor
systems, and maintenance contracts will
have to be reconsidered and reallocated
within a very short period of time to
accommodate the delay. Many covered
entities have also begun to train their
staff for ICD–10 implementation and
must decide immediately whether to
continue this training. The absence of a
firm implementation date impedes
decision-making for budgetary
development, projecting planning, and
systems preparation. If covered entities
are unable to make these decisions
timely, some may choose to slow or
even suspend ICD–10 preparations.
Covered entities will also have to
accomplish systems and business
process changes in a relatively short
period of time. Many providers have
programmed their IT systems to submit
ICD–10 codes on October 1, 2014, and
have implemented changes in business
processes to accommodate these
changes. Most health plans have
programmed their claims processing
systems to accept and process ICD–10
codes on October 1, 2014. These
systems will have to be reconfigured to
process ICD–9–CM coded claims for an
additional year while also preparing to
process ICD–10 coded claims on and
after October 1, 2015. It is imperative
that covered entities know the new
compliance dates now so they can begin
immediately to take the necessary steps
to comply.
A seamless industry transition to a
required code set is necessary in order
to avoid payment disruptions. If covered
entities are not prepared to accept and
process ICD–9–CM codes on October 1,
2014, there could be significant
disruptions in health care payments.
The inability of health plans to
successfully process claims directly
impacts the timeliness of provider
reimbursements for services rendered.
Many providers, especially small and
rural providers, rely on the timeliness of
payments in order to continue to do
business. A risk to a provider’s
PO 00000
Frm 00046
Fmt 4700
Sfmt 4700
economic well-being is a risk to patient
care.
In order to minimize industry
disruption, it is important for the
Secretary to announce the new
compliance dates as soon as possible.
Even with the extra few months this
final rule affords, time is short. If we
were to engage in full notice and
comment rulemaking, covered entities
would be left with uncertainty until a
final rule could be published, which
would be unlikely to happen prior to
October 1, 2014. And even if the process
could be expedited, a final rule would
be issued too close to October 1, 2014
to give most covered entities sufficient
time to comply with the requirements of
the rule. Accordingly, we find there is
good cause to waive the normal notice
and comment rulemaking procedures, as
they are impracticable and contrary to
the public interest.
IV. Collection of Information
Requirements
This document does not impose
information collection and
recordkeeping requirements.
Consequently, it does not require a
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995.
V. Regulatory Impact Analysis
A. Statement of Need
As stated previously, section 212 of
PAMA specifies that ‘‘[t]he Secretary of
Health and Human Services may not,
prior to October 1, 2015, adopt ICD–10
code sets as the standard for code sets
under section 1173(c) of the Social
Security Act (42 U.S.C. 1320d–2(c)) and
section 162.1002 of title 45, Code of
Federal Regulations.’’ This final rule
establishes a new ICD–10 compliance
date of October 1, 2015. It also requires
the continued use of ICD–9–CM through
September 30, 2015.
B. Overall Impact
We have examined the impacts of this
final rule as required by Executive
Order 12866 on Regulatory Planning
and Review (September 30, 1993, as
further amended), Executive Order
13563 on Improving Regulation and
Regulatory Review (January 18, 2011),
section 202 of the Unfunded Mandates
Reform Act of 1995 (Pub. L. 104–4),
Executive Order 13132 on Federalism
(August 4, 1999), and the Congressional
Review Act (5 U.S.C. 804(2)).
Executive Orders 12866 and 13563
direct agencies to assess all costs and
benefits of available regulatory
alternatives and, if regulation is
necessary, to select regulatory
E:\FR\FM\04AUR1.SGM
04AUR1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Rules and Regulations
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). Section 3(f) of Executive Order
12866 defines a ‘‘significant regulatory
action’’ as an action that is likely to
result in a rule: (1) Having an annual
effect on the economy of $100 million
or more in any 1 year, or adversely and
materially affecting a sector of the
economy, productivity, competition,
jobs, the environment, public health or
safety, or state, local or tribal
governments or communities (also
referred to as ‘‘economically
significant’’); (2) creating a serious
inconsistency or otherwise interfering
with an action taken or planned by
another agency; (3) materially altering
the budgetary impacts of entitlement
grants, user fees, or loan programs or the
rights and obligations of recipients
thereof; or (4) raising novel legal or
policy issues arising out of legal
mandates, the President’s priorities, or
the principles set forth in the Executive
Order.
A regulatory impact analysis (RIA)
must be prepared for major rules with
economically significant effects ($100
million in 1995 dollars or more in any
one year). We estimate that this rule is
‘‘economically significant’’ as measured
by the $100 million threshold, and
hence also a major rule under the
Congressional Review Act. Accordingly,
we have prepared a Regulatory Impact
Analysis (RIA) that presents the costs
and benefits of this rule.
In determining the costs of this final
rule, we needed to establish, as a
baseline, what costs would likely be
incurred absent this final rule, and then
compare this baseline to the costs of the
ICD–10 delay announced in this final
rule. The costs estimated in this RIA
include costs to industry and
government entities for an October 1,
2015 compliance date. For the RIA in
this final rule we have also relied
largely on the estimates in the RIA of
the 2012 ICD–10 Delay final rule
because that rule also estimated the cost
of a 1-year delay in the compliance date
for ICD–10.
Section 202 of the Unfunded
Mandates Reform Act of 1995 (UMRA)
also requires that agencies assess
anticipated costs and benefits before
issuing any rule whose mandates
require spending in any one year of
$100 million in 1995 dollars, updated
annually for inflation. In 2014, that
threshold is approximately $141
million. This final rule contains a
mandate that would likely impose
spending costs on the healthcare
industry of more than $141 million.
VerDate Mar<15>2010
16:31 Aug 01, 2014
Jkt 232001
Therefore, in this RIA we illustrate the
costs of the 1-year delay in compliance
date for ICD–10.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a final
rule that imposes substantial direct
requirement costs on State and local
governments, preempts State laws, or
otherwise has Federalism implications.
We do not anticipate that the 1-year
delay in the compliance date for ICD–
10 will have a significant impact on
State and local governments, preempt
State laws, or otherwise have
Federalism implications.
C. Anticipated Effects on Impacted
Entities
ICD codes are used in nearly every
sector of the health care industry. All
HIPAA covered entities will be affected
by a delay in the compliance date of
ICD–10. Covered entities include all
health plans, health care clearinghouses,
and health care providers that transmit
health information in electronic form in
connection with a transaction for which
the Secretary has adopted a standard.
While covered entities are required to
transition to ICD–10, many other
entities not covered by HIPAA also use
ICD codes for a variety of purposes
because their operational and business
needs often intersect with those of
covered entities. For practical and
business purposes, we expect these noncovered entities will voluntarily
transition to ICD–10. Entities that are
not considered covered entities, but that
may be affected by the transition to
ICD–10, include: Workers’
compensation programs and automobile
and personal liability insurers,
hardware and software vendors for
health care practice management
systems and electronic health record
systems, researchers, public health
organizations, educational institutions,
and coding entities.
D. Scope and Methodology of the
Impact Analysis for ICD–10
This RIA estimates the costs of a delay
of compliance with ICD–10. In this RIA
we are analyzing only the impact of a
delay, not the impact of ICD–10
implementation, which we addressed in
the 2008 ICD–10 proposed rule (73 FR
49476) and the January 2009 ICD–10
final rule (74 FR 3328). For purposes of
this analysis, we reference estimates
made in the RIA of the 2012 ICD–10
Delay final rule because it also delayed
compliance with ICD–10 by 1 year.
While we assume that a delay of the
implementation of ICD–10 will affect a
broad range of health care providers, as
illustrated in Table 1, we only examine
PO 00000
Frm 00047
Fmt 4700
Sfmt 4700
45131
the costs and benefits of a delay on two
types of health care providers: Hospitals
and small providers. We do not analyze
the impact on other providers,
including, but not limited to, nursing
and residential care facilities, dentists,
or durable medical equipment (DME)
suppliers, though we understand that
there is likely to be an impact on most
of these providers. As was the case for
our impact analysis in the 2008 ICD–10
proposed rule, there continues to be
very little publicly available data on the
use of electronic data interchange (EDI)
among dentists, DME suppliers, nursing
homes, and residential care facilities.
The lack of data for these types of health
care providers has been noted in other
studies on administrative
simplification.3
We do not include an analysis of costs
or benefits to health care clearinghouses
and transaction vendors in this RIA.
Transaction vendors are entities that
process claims or payments for entities
such as health plans. Not all transaction
vendors meet the HIPAA definition of a
health care clearinghouse, which
constitute a subset of transaction
vendors. Payment vendors also would
be a type of transaction vendor—a
transaction vendor that ‘‘associates’’ or
‘‘re-associates’’ health care claim
payments with the payments’
remittance advice for either a health
plan or provider. For our purposes,
transaction vendors do not include
developers or retailers of computer
software or entities that are involved in
installing, programming or maintaining
computer software. However, we did
not calculate costs and benefits to health
care clearinghouses and transaction
vendors in this RIA because, as in our
previous impact analyses in the August
2008 ICD–10 proposed rule and the
2012 ICD–10 Delay final rule, we
assume that any associated costs and
benefits will be passed on to the health
plans or providers and will be included
in the costs and benefits we apply to
health plans and providers.
Although self-insured group health
plans meet the HIPAA definition of
‘‘health plan,’’ we did not include them
in this impact analysis. While selfinsured group health plans will be
required to implement ICD–10, we
assume that, with a few exceptions,
such plans do not send or receive
HIPAA electronic transactions because
3 ‘‘Excess Billing and Insurance-Related
Administrative Costs,’’ by James Kahn, in The
Healthcare Imperative; Lowering Costs and
Improving Outcomes: Workshop Series Summary,
edited by Pierre L. Yong, Robert S. Saunders, and
Leigh Anne Olsen, Institute of Medicine of the
National Academies, the National Academies Press,
Washington, DC: 2010.
E:\FR\FM\04AUR1.SGM
04AUR1
45132
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Rules and Regulations
most are not involved in the day-to-day
activities of a health plan, and outsource
those services to third party
administrators (TPAs) or transaction
vendors.
We do delineate a cost to TPAs in this
RIA. Although TPAs do not meet the
definition of ‘‘health plans,’’ and
therefore are not required by HIPAA to
use code sets such as ICD–10, as a
practical matter they will need to make
the transition in order to continue to
conduct electronic transactions on
behalf of self-insured group health
plans. The impact of a delay of the
compliance date of ICD–10 on TPAs
will be similar to the commercial
insurer cost/benefit impact profile as
TPAs serve a similar function and will
have to implement and test their
systems in the same manner as health
plans. Therefore, when we refer to
‘‘commercial health plans’’ in this RIA,
we are including TPAs in the category
of ‘‘small health plans’’ in the RIA.
In the 2012 ICD–10 Delay final rule
(77 FR 22991) and in this RIA, we do
not include the costs for software
vendors, including software vendors for
practice management and EHR systems,
as they ultimately pass their costs to
their clients.
mstockstill on DSK4VPTVN1PROD with NOTICES
E. Cost of a 1-Year Delay of
Implementation of ICD–10 for Health
Plans
1. Cost of a 1-Year Delay to Commercial
Health Plans and TPAs
Health plans are a varied group in
terms of size, and the cost of a delay is
calculated using a range that reflects
this variance. In terms of costs,
commercial health plans are far along in
their ICD–10 implementation and have
devoted funds, resources, and staff to
the effort. When PAMA was enacted,
the majority of commercial health plans
were in the external testing phase of
their ICD–10 implementation plans.4 A
1-year delay of ICD–10 compliance will
allow entities more time to thoroughly
test, but the testing and the continued
maintenance of contracts and personnel
required for the transition will be 1year longer than was budgeted.
Continued training, testing, and
retention of personnel, and contracts are
expected to be the primary costs
associated with a 1-year delay for
commercial health plans. Commercial
health plans will perform additional
work in preparing their systems to
4 Twenty of the top 25 health insurance
companies indicated that they were prepared to test
with trading partners, according to a scan of their
Web sites. The top 25 health insurance companies
were identified by US News (https://health.usnews.
com/health-news/health-insurance/articles/2013/
12/16/top-health-insurance-companies).
VerDate Mar<15>2010
16:31 Aug 01, 2014
Jkt 232001
process ICD–9 coded claims for an
additional year while also converting
their systems to process ICD–10 coded
claims on and after October 1, 2015. We
estimate the costs of the delay for
commercial health plans and third party
administrators to be between $547
million and $2,786 million.
2. Cost of a 1-Year Delay to Medicare
We believe many government health
programs were prepared to be ICD–10
compliant on October 1, 2014, and, like
commercial payers, will incur costs
from a 1-year delay. As an example,
components affected by a 1-year delay at
the Centers for Medicare & Medicaid
Services (CMS), in particular, Medicare
Fee-for-Service (herein referred to as
Medicare), estimate that there will be
additional costs. Like other government
payers, Medicare has programmed its
claims processing systems to accept and
process ICD–10 codes on October 1,
2014. These systems will have to be
reconfigured to process ICD–9–CMcoded claims for an additional year
while also preparing to process ICD–10coded claims on and after October 1,
2015. Therefore, costs include
expenditures like extending contracts
and reprogramming work for the ICD–9–
CM systems and ICD–10 systems while
continuing to test ICD–10 in the new
2015 systems environment. Other
additional costs include an increased
need for outreach and education claims
processing manual updates, technical
assistance, and training.
It was estimated in the 2012 final rule
that a 1-year delay of ICD–10
compliance would be reflected by
additional work at an estimated total
cost of $5 to $10 million for the
Medicare program. Because the
Medicare program was so far along in its
ICD 10 implementation when PAMA
was enacted, we now estimate that the
cost of a 1 year delay will be $21 to $32
million for the Medicare program spread
across FYs 2014 and 2015.
3. Cost of a 1-Year Delay to State
Medicaid Agencies
State Medicaid Agencies (SMAs)
completed a cost impact assessment for
a 1-year delay in April of 2014. SMAs
face similar costs as commercial health
plans as a result of the 1-year delay of
ICD–10. SMAs will incur costs due to
contractual obligations which may
require modifications, extensions, or
procurements. Other costs to SMAs
include the need to test ICD–10 codes in
the new 2015 systems environment,
which will be needed even by SMAs
that have successfully tested to date.
SMA resources will need to be
maintained at full pre-implementation
PO 00000
Frm 00048
Fmt 4700
Sfmt 4700
and go-live levels through 2015 in order
to prepare for the October 1, 2015
implementation. These will likely affect
planning and implementation of other
IT initiatives for SMAs, potentially
resulting in additional costs and delays
for those initiatives. SMAs report the
total cost for both state and federal of a
1-year delay for all SMAs is $169 to
$182 million.
F. Cost of a 1-Year Delay to Providers
1. Hospitals and Large Providers
We expect that many hospitals and
large provider organizations have
already spent funds in preparation for
the ICD–10 transition. As with health
plans, a delay of the compliance date
will add to their costs because large
providers must maintain personnel
staffing levels, make significant system
changes; renegotiate the contracts
necessary to extend preparations an
extra year, and retest systems in the new
2015 systems environment. Likewise,
large providers must maintain
technological resources for an extra
year.
According to our estimates in the
2012 ICD–10 delay final rule, the cost of
a 1-year delay to hospitals and large
physician practices will be $409 million
to $3.7 billion.
2. Small Providers
There are some surveys that estimate
the associated costs for providers
transitioning to ICD–10, and we
referenced some of these studies in the
2012 ICD–10 Delay proposed rule (77
FR 22997). In that proposed rule, we did
not estimate the cost to small providers
of the 1-year delay because these costs
were negligible.
Given the lack of statistically valid
data regarding the resources small
providers have expended, as well as
their state of readiness for an October 1,
2014 compliance date as compared to an
October 1, 2015 compliance date, we do
not estimate the cost or benefits to small
providers in this RIA. However, based
on other relevant areas of the health care
industry, we assume that the change in
compliance date will negatively impact
some percentage of small providers in
terms of cost. Nonetheless, the 1-year
delay may also give relief to small
providers that were not prepared by
affording them another year in which to
spread costs and resources.
G. Summary of Costs of a 1-Year Delay
of the Compliance Date of ICD–10
Except for estimates of the impact on
Medicare and State Medicaid agencies,
we are using the cost estimates from the
2012 ICD–10 Delay final rule to
E:\FR\FM\04AUR1.SGM
04AUR1
45133
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Rules and Regulations
conclude that a 1-year delay of the ICD–
10 compliance date would add a range
of 10 to 30 percent to the total cost that
these entities have already spent or
budgeted for an October 1, 2014
implementation date, for an additional
cost to commercial entities of
approximately $1 billion to $6.8 billion.
We summarize the range of low and
high estimates of a 1-year delay of the
compliance date for ICD–10 in Table 1.
TABLE 1—SUMMARY OF COSTS IN 2015 OF A 1-YEAR DELAY IN THE COMPLIANCE DATE OF ICD–10 *
Low
(in millions)
Cost
Cost
Cost
Cost
to
to
to
to
High
(in millions)
Mean
(average)
(in millions)
Commercial Health Plans ...................................................................................
Medicare .............................................................................................................
State Medicaid Agencies ....................................................................................
Hospitals and Large Provider Organizations ......................................................
$547
21
169
422
$2,786
32
182
3,849
$1,667
27
176
2,136
Total Costs ...............................................................................................................
1,161
6,850
4,007
* In 2014 Dollars.
mstockstill on DSK4VPTVN1PROD with NOTICES
H. Considered Alternatives to a 1-Year
Delay of the ICD–10 Compliance Date
Section 212 of PAMA states that ‘‘the
Secretary of Health and Human Services
may not, prior to October 1, 2015, adopt
ICD–10 code sets as the standard for
code sets under section 1173(c) of the
Social Security Act (42 U.S.C. 1320d–
2(c)) and section 162.1002 of title 45,
Code of Federal Regulations.’’ We
interpret the statute as mandating a
delay of the compliance date of ICD–10,
and permitting the Secretary discretion
to select the length of the delay, as long
as implementation is required no sooner
than October 1, 2015. This final rule
adopts a compliance date of October 1,
2015.
We considered a number of delays of
different durations before establishing
October 1, 2015 as the compliance date
for ICD–10. However, we concluded that
a delay beyond 1 year would be
significantly more costly and have a
damaging impact on industry. For
example, extending the delay beyond 1
year could render current ICD–10
system updates and releases obsolete,
which would diminish the investments
stakeholders have already made to
prepare for the ICD–10 transition. All
segments of the health care industry
have invested significant time and
resources in financing, training, and
implementing necessary changes to
systems, workflow processes, and
clinical documentation practices.
Stakeholders would need to restart their
system preparation and would not be
able to leverage past system
investments.
As estimated in the 2012 ICD–10
Delay final rule 5 and repeated in this
final rule, a 1-year delay increases costs
5 Administrative Simplification: Adoption of a
Standard for a Unique Health Plan Identifier;
Addition to the National Provider Identifier
Requirements; and a Change to the Compliance
Date for the International Classification of Diseases,
VerDate Mar<15>2010
16:31 Aug 01, 2014
Jkt 232001
for covered entities by a range of 10 to
30 percent. As indicated in the RIA in
this final rule, we estimate little to no
benefit or cost savings in delays of ICD–
10 beyond the minimum 1-year delay
required by PAMA. Although industry
readiness has not been studied,
stakeholders representing a significant
majority of the industry have reported
that they invested significant time and
resources and were prepared for the
October 1, 2014 ICD–10 compliance
date. A delay of longer than 1 year
would slow or stop progress towards
ICD–10 implementation, delay the
efficiencies that can be achieved
through ICD–10 implementation, and
create wasteful spending. Therefore, we
believe that an October 1, 2015
compliance date is the most appropriate
alternative.
I. Regulatory Flexibility Analysis:
Impact on Small Providers of a Delay in
the Compliance Date of ICD–10
The Regulatory Flexibility Act (RFA)
of 1980 (Pub. L. 96–354) requires
agencies to describe and analyze the
impact of the final rule on small entities
unless the Secretary can certify that the
regulation will not have a significant
impact on a substantial number of small
entities. According to the Small
Business Administration’s size
standards, a small entity is defined as
follows according to health care
categories: Office of Physicians are
defined as small entities if they have
revenues of $11 million or less; most
other health care providers (dentists,
chiropractors, optometrists, mental
health specialists) are small entities if
they have revenues of $7.5 million or
less; hospitals are small entities if they
have revenues of $38.5 million or less.
10th Edition (ICD–10–CM and ICD–10–PCS)
Medical Data Code Sets; Final Rule. https://www.
gpo.gov/fdsys/pkg/FR-2012-09-05/pdf/201221238.pdf pages 50–53.
PO 00000
Frm 00049
Fmt 4700
Sfmt 4700
(For details, see the SBA’s Web site at
https://www.sba.gov/sites/default/files/
Size_Standards_Table.pdf. Refer to
Sector 62—Health Care and Social
Assistance).
As in the 2012 Delay final rule, we
continue to assume for purposes of the
RFA, that all physician practices are
small entities. We conclude that a 1-year
delay in implementation of the ICD–10
will affect a ‘‘substantial number’’ of
small entities. However, we assert in
this final rule, that the 1-year delay of
the compliance date of ICD–10 will be
more beneficial to small entities than it
will be burdensome. The benefits are
derived from the additional time that
small entities will have for ICD–10
implementation. Therefore, we certify
that the provisions in this final rule will
not have a significant economic impact
on a substantial number of small
entities.
J. Accounting Statement and Table
The total costs of a 1-year delay of the
compliance date will likely be incurred
over a 12-month period. However, due
to the range of impacted entities,
including educational institutions, those
12 months may span different dates and
different budget periods. Given the
diverse approaches to budgeting in the
industry, there is no precise way of
calculating how much of the cost and
cost avoidance falls outside of the
October 1, 2014 to October 1, 2015
timeframe. For simplicity’s sake, we
calculate costs of a delay of the
compliance date for ICD–10 as occurring
in calendar year 2015.
As required by OMB Circular A–4,6
Table 2 is an accounting statement
showing the classification of the
expenditures associated with the
6 ‘‘Circular A–4,’’ September 17, 2003, Office of
Management and Budget (OMB), https://www.
whitehouse.gov/omb/circulars_a004_a-4/.
E:\FR\FM\04AUR1.SGM
04AUR1
45134
Federal Register / Vol. 79, No. 149 / Monday, August 4, 2014 / Rules and Regulations
provisions of this final rule. Table 2
provides our best estimates of the costs
and benefits associated with a 1-year
delay of the compliance date of ICD–10.
TABLE 2—ACCOUNTING STATEMENT: CLASSIFICATION OF ESTIMATED EXPENDITURES FOR 1-YEAR DELAY OF ICD–10
COMPLIANCE DATE FROM FY 2014 TO FY 2015
[In millions of dollars]
Primary estimate
(millions)
Category
Minimum
estimate
(millions)
Maximum
estimate
(millions)
Source citation
(RIA, preamble,
etc.)
COSTS
Annualized Monetized costs:
7% Discount ..............................................................................
3% Discount ..............................................................................
List of Subjects in 45 CFR Part 162
§ 162.1002
Administrative practice and
procedures, Electronic transactions,
Health facilities, Health insurance,
Hospitals, Incorporation by reference,
Medicaid, Medicare, Reporting and
recordkeeping requirements.
$4,007.0
4,007.0
■
For the reasons set forth in the
preamble, the Department of Health and
Human Services amends 45 CFR Part
162 as follows:
[Amended]
2. Section 162.1002 is amended as
follows:
■ A. In paragraph (b) introductory text
by removing the date ‘‘September 30,
2014’’ and adding in its place the date
‘‘September 30, 2015’’.
■ B. In paragraph (c) introductory text
by removing the date ‘‘October 1, 2014’’
and adding in its place the date
‘‘October 1, 2015’’.
1. The authority citation for part 162
continues to read as follows:
Authority: Secs. 1171 through 1180 of the
Social Security Act (42 U.S.C. 1320d–1320d–
9), as added by sec. 262 of Pub. L. 104–191,
110 Stat 2021–2031, sec. 105 of Pub. L. 110–
233, 122 Stat. 881–992, and sec. 264 of Pub.
L. 104–191, 110 Stat 2033–2034 (42 U.S.C.
1320d–2 (note)), secs. 1104 and 10109 of Pub.
L. 111–148, 124 Stat 146–154 and 915–917.
[FR Doc. 2014–18347 Filed 7–31–14; 4:15 pm]
mstockstill on DSK4VPTVN1PROD with NOTICES
■
VerDate Mar<15>2010
16:31 Aug 01, 2014
Jkt 232001
BILLING CODE 4120–01–P
PO 00000
$6,850.0
6,850.0
RIA.
RIA.
DEPARTMENT OF TRANSPORTATION
Dated: July 17, 2014.
Marilyn Tavenner,
Administrator, Centers for Medicare &
Medicaid Services.
Approved: July 25, 2014.
Sylvia M. Burwell,
Secretary, Department of Health and Human
Services.
PART 162—ADMINISTRATIVE
REQUIREMENTS
$1,161.0
1,161.0
Federal Railroad Administration
49 CFR Part 214
Railroad Workplace Safety
CFR Correction
In Title 49 of the Code of Federal
Regulations, Parts 200 to 299, revised as
of October 1, 2013, on page 189, in
§ 214.315, paragraph (b) is reinstated to
read as follows:
■
§ 214.315 Supervision and
communication.
*
*
*
*
*
(b) A job briefing for on-track safety
shall be deemed complete only after the
roadway worker has acknowledged
understanding of the on-track safety
procedures and instructions presented.
*
*
*
*
*
[FR Doc. 2014–18425 Filed 8–1–14; 8:45 am]
BILLING CODE 1505–01–D
Frm 00050
Fmt 4700
Sfmt 9990
E:\FR\FM\04AUR1.SGM
04AUR1
Agencies
[Federal Register Volume 79, Number 149 (Monday, August 4, 2014)]
[Rules and Regulations]
[Pages 45128-45134]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-18347]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
45 CFR Part 162
[CMS-0043-F]
RIN 0938-AS31
Administrative Simplification: Change to the Compliance Date for
the International Classification of Diseases, 10th Revision (ICD-10-CM
and ICD-10-PCS) Medical Data Code Sets
AGENCY: Office of the Secretary, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This final rule implements section 212 of the Protecting
Access to Medicare Act of 2014 by changing the compliance date for the
International Classification of Diseases, 10th Revision, Clinical
Modification (ICD-10-CM) for diagnosis coding, including the Official
ICD-10-CM Guidelines for Coding and Reporting, and the International
Classification of Diseases, 10th Revision, Procedure Coding System
(ICD-10-PCS) for inpatient hospital procedure coding, including the
Official ICD-10-PCS Guidelines for Coding and Reporting, from October
1, 2014 to October 1, 2015. It also requires the continued use of the
International Classification of Diseases, 9th Revision, Clinical
Modification, Volumes 1 and 2 (diagnoses), and 3 (procedures) (ICD-9-
CM), including the Official ICD-9-CM Guidelines for Coding and
Reporting, through September 30, 2015.
DATES: These regulations are effective on September 3, 2014.
FOR FURTHER INFORMATION CONTACT:
Denesecia Green, (410) 786-8797.
Geanelle G. Herring, (410) 786-4466.
Kamahanahokulani Farrar, (410) 786-2155.
SUPPLEMENTARY INFORMATION:
I. Executive Summary and Background
A. Executive Summary
1. Purpose
Prior to the enactment of the Protecting Access to Medicare Act of
2014 (PAMA) (Pub. L. 113-93) on April 1, 2014, the health care industry
was actively preparing to transition to the International
Classification of Diseases, 10th Revision, Clinical Modification (ICD-
10-CM) for diagnosis coding and the International Classification of
Diseases, 10th Revision, Procedure Coding System (ICD-10-PCS) for
inpatient hospital procedure coding (herein collectively referred to as
ICD-10) on October 1, 2014. Many in the health care industry had
invested time and resources in system upgrades, testing, training, and
undertaking the necessary changes to workflow processes. However, PAMA
required the Secretary to adopt ICD-10 no sooner than October 1, 2015.
This final rule establishes October 1, 2015, as the new ICD-10
compliance date. This final rule also requires the continued use of the
International Classification of Diseases, 9th Revision, Clinical
Modification, Volumes 1 and 2 (diagnoses), and 3 (procedures),
including the Official ICD-9-CM Guidelines for Coding and Reporting
(herein collectively referred to as ICD-9-CM), through September 30,
2015.
a. Need for the Regulatory Action
This final rule establishes October 1, 2015 as the compliance date
for ICD-10. It also requires the continued use of ICD-9-CM through
September 30, 2015.
b. Legal Authority for the Regulatory Action
Section 212 of PAMA, titled ``Delay in Transition from ICD-9-CM to
ICD-10 Code Sets'' is the legal authority for the regulatory action.
2. Summary of the Major Provisions
As noted previously, this final rule changes the compliance date
for ICD-10 from October 1, 2014 to October 1, 2015 and requires covered
entities to continue using ICD-9-CM through September 30, 2015.
3. Summary of Costs and Benefits
In the September 5, 2012 Federal Register (77 FR 54664), the
Department of Health and Human Services (HHS) published a final rule
titled ``Administrative Simplification: Adoption of a Standard for a
Unique Health Plan Identifier; Addition to the National Provider
Identifier
[[Page 45129]]
Requirements; and a Change to the Compliance Date for the International
Classification of Diseases, 10th Edition (ICD-10-CM and ICD-10-PCS)
Medical Data Code Sets'' (herein referred to as the 2012 ICD-10 Delay
final rule) in which the Secretary changed the compliance date for ICD-
10 from October 1, 2013 to October 1, 2014. In that rule, we estimated
there would be a significant cost to industry from a delay of ICD-10
because commercial health plans, medium and large hospitals, and large
physician practices were far along in their implementation and had
devoted funds, resources, and staff to the effort. In our analysis, we
estimated that a 1-year delay of the compliance date for ICD-10 would
add a range of 10 to 30 percent to the total cost that these entities
had already spent or budgeted for the transition to ICD-10 on October
1, 2013.
We use the same rationale and methodology in our analysis of costs
and benefits in the Regulatory Impact Analysis (RIA) of this final
rule, and conclude that a delay of 1-year, as opposed to a longer
delay, will be the least costly and most fiscally responsible way to
implement the requirements of section 212 of PAMA. We estimate the cost
of a 1-year delay to HIPAA covered entities will be $1.1 to $6.8
billion.
B. Background
In the January 16, 2009 Federal Register (74 FR 3328), HHS
published a final rule (herein referred to as the 2009 ICD-10 final
rule) in which the Secretary adopted ICD-10 as the Health Insurance
Portability and Accountability Act of 1996 (HIPAA) standard code set to
replace ICD-9-CM. The 2009 ICD-10 final rule established an October 1,
2013 compliance date for ICD-10. For more background on the adoption of
ICD-10, see the 2009 ICD-10 final rule and the August 22, 2008 proposed
rule titled ``HIPAA Administrative Simplification: Modification to
Medical Data Code Set Standards to Adopt ICD-10-CM and ICD-10-PCS''
(herein referred to as the 2008 ICD-10 proposed rule) (73 FR 49796).
In late 2011 and early 2012, three issues emerged that led the
Secretary to reconsider the compliance date for ICD-10: (1) The
industry transition to ASC X12 Version 5010 did not proceed as
effectively as expected; (2) providers became concerned that other
statutory initiatives were stretching their resources; and (3) there
was a lack of readiness for the ICD-10 transition, as indicated by
industry surveys and polls. As a result, HHS published the 2012 ICD-10
Delay final rule in which the compliance date for ICD-10 was delayed
from October 1, 2013 to October 1, 2014.
II. Provisions of the Final Rule
Section 212 of PAMA provides that the Secretary may not adopt ICD-
10 under HIPAA prior to October 1, 2015. We interpret this provision as
requiring the Secretary to delay the October 1, 2014 implementation of
ICD-10, and we believe the provision gives the Secretary discretion to
choose a new compliance date of October 1, 2015, or later. We are
establishing October 1, 2015 as the new compliance date.
All segments of the health care industry have invested significant
time and resources in financing, training, and implementing necessary
changes to systems, workflow processes, and clinical documentation
practices in order to prepare for ICD-10. The American Academy of
Professional Coders (AAPC) provides training and education to medical
coders, physicians and their practice management staff. In a June 2014
survey \1\ of 5,000 AAPC members, nearly 75 percent of the survey
respondents reported that they are making significant progress toward
preparing for ICD-10 implementation. The survey also indicated that
about 25 percent of those surveyed had completed all of the necessary
ICD-10 training; 13 percent indicated that they were prepared for the
October 1, 2014 implementation date; and 23 percent were actively
testing with their ICD-10 vendors when PAMA was signed into law. The
industry has made significant progress toward ICD-10 compliance and has
gained momentum in its efforts. A delay of longer than 1 year would
slow or even stop progress towards ICD-10 implementation. In order to
preserve this momentum and encourage continued compliance efforts, we
are establishing the shortest delay permitted by law, which is 1 year.
---------------------------------------------------------------------------
\1\ ICD-10 Monitor: Exclusive: ICD-10 Implementation--Where Do
We Really Stand? https://icd10monitor.com/enews/item/1220-exclusive-icd-10-implementation-where-do-we-really-stand?utm_source=Real%20Magnet&utm_medium=Email&utm_campaign=42358626.
---------------------------------------------------------------------------
Additionally, we believe it is important to require implementation
of ICD-10 as soon as the law permits because it will allow the industry
to begin reaping the benefits of ICD-10 as soon as possible. ICD-10
provides greater specificity of diagnosis-related groups; improves
quality measurement and reporting capabilities; improves tracking of
illnesses; and reflects greater accuracy of reimbursement for medical
services. ICD-10's granularity will improve data capture and analytics
of public health surveillance and reporting, national quality
reporting, research and data analysis, and provide detailed data to
inform health care delivery and health policy decisions.
ICD-10 reflects the advances in medicine and medical technology
that U.S. physician specialty groups called for as they provided
extensive input into the development of the ICD-10-CM code-set to
capture more precise codes for the conditions they treat. ICD-10
includes significant improvements over ICD-9-CM in coding primary care
encounters, external causes of injury, mental disorders, and preventive
health. For example, ICD-10 reflects improved diagnosis of chronic
illness and identifies underlying causes, complications of disease, and
conditions that contribute to the complexity of a disease, and captures
the severity and stage of diseases such as chronic kidney disease,
dementia, and asthma.
Finally, a 1-year delay, as opposed to a longer delay, is the least
expensive option for the industry. As estimated in the 2012 ICD-10
Delay final rule \2\ and repeated in this final rule, a 1-year delay
increases costs for covered entities by a range of 10 to 30 percent. We
conclude that a delay beyond 1 year would be significantly more costly
and have a damaging impact on the healthcare industry. For example,
extending the delay beyond 1 year could render current ICD-10 system
updates and releases obsolete, which would diminish the investments
stakeholders have already made to prepare for the ICD-10 transition.
Stakeholders would need to restart their system preparation and would
not be able to leverage past system investments.
---------------------------------------------------------------------------
\2\ Administrative Simplification: Adoption of a Standard for a
Unique Health Plan Identifier; Addition to the National Provider
Identifier Requirements; and a Change to the Compliance Date for the
International Classification of Diseases, 10th Edition (ICD-10-CM
and ICD-10-PCS) Medical Data Code Sets; Final Rule. https://www.gpo.gov/fdsys/pkg/FR-2012-09-05/pdf/2012-21238.pdf pages 50-53.
---------------------------------------------------------------------------
In order to implement section 212 of PAMA, we are changing the
compliance date for ICD-10 from October 1, 2014 to October 1, 2015 in
45 CFR 162.1002(c) by changing ``October 1, 2014'' to ``October 1,
2015'' to read, ``[f]or the period on and after October 1, 2015.''
Our regulations at 45 CFR 162.1002(b) currently require compliance
with ICD-9-CM through September 30, 2014. We are changing our
regulations to require the continued use of ICD-9-CM through September
30, 2015. Accordingly, we are revising 45 CFR 162.1002(b) by
[[Page 45130]]
changing ``September 30, 2014'' to ``September 30, 2015'' to read,
``[f]or the period on and after October 16, 2003 through September 30,
2015.''
III. Waiver of Proposed Rulemaking
Under 5 U.S.C. 553(b) of the Administrative Procedure Act (APA), we
are required to publish a notice of proposed rulemaking (NPRM) in the
Federal Register. Section 553(b) of the APA provides an exception to
this requirement. Section 553(b)(B) of the APA authorizes HHS to waive
normal rulemaking requirements if it finds that notice and comment
procedures are impracticable, unnecessary, or contrary to the public
interest. We believe waiving normal notice and comment rulemaking
requirements is justified because covered entities need to know how to
proceed with respect to ICD-9-CM and ICD-10 now, or they will not have
adequate time to prepare to accurately submit, process, and pay for
health care claims.
The October 1, 2014 compliance date for ICD-10 was established in
the 2012 ICD-10 Delay final rule. Section 212 of PAMA was enacted on
April 1, 2014, six months prior to the October 1, 2014 ICD-10
compliance date, at a critical time when most health care entities had
already configured and tested systems and business processes, and
devoted staff and financial resources in preparation for compliance on
October 1, 2014. IT systems were changed to align with new payment
policies and rules, staff was trained on new workflow processes, and
trading partner agreements were updated to begin using ICD-10 on
October 1, 2014.
After section 212 of PAMA was enacted, many industry stakeholders
asked the Secretary to clarify which ICD version could or must be used
and when. Many interpreted section 212 of PAMA as requiring a delay of
ICD-10 to October 1, 2015, while others interpreted the law as allowing
the Secretary to postpone implementation of ICD-10 for longer than a
year. Other industry stakeholders suggested that section 212 of PAMA
permitted covered entities to use either ICD-9-CM or ICD-10 on October
1, 2014. These widely different interpretations reflected the
industry's uncertainty about when it would be required to use specific
versions of the ICD coding system, and we recognized a growing
apprehension among stakeholders in light of this uncertainty.
There are also a number of important business and implementation
decisions that industry stakeholders have to make now. For example,
budgeting, project management, and systems planning for the continued
use of ICD-9-CM on October 1, 2014 and for the delayed implementation
of ICD-10 on October 1, 2015, must begin as soon as possible for all
covered entities. Both large and small providers and health plans
generally develop budgets and allot resources for transitions far in
advance and particularly for those transitions that impact IT systems,
business policies, and processes. Most covered entities have allocated
funds, assigned human resources, and have employed contractors to
assist with or manage various aspects of the transition to ICD-10 based
on an October 1, 2014 compliance date. These resources, trading partner
agreements, vendor systems, and maintenance contracts will have to be
reconsidered and reallocated within a very short period of time to
accommodate the delay. Many covered entities have also begun to train
their staff for ICD-10 implementation and must decide immediately
whether to continue this training. The absence of a firm implementation
date impedes decision-making for budgetary development, projecting
planning, and systems preparation. If covered entities are unable to
make these decisions timely, some may choose to slow or even suspend
ICD-10 preparations.
Covered entities will also have to accomplish systems and business
process changes in a relatively short period of time. Many providers
have programmed their IT systems to submit ICD-10 codes on October 1,
2014, and have implemented changes in business processes to accommodate
these changes. Most health plans have programmed their claims
processing systems to accept and process ICD-10 codes on October 1,
2014. These systems will have to be reconfigured to process ICD-9-CM
coded claims for an additional year while also preparing to process
ICD-10 coded claims on and after October 1, 2015. It is imperative that
covered entities know the new compliance dates now so they can begin
immediately to take the necessary steps to comply.
A seamless industry transition to a required code set is necessary
in order to avoid payment disruptions. If covered entities are not
prepared to accept and process ICD-9-CM codes on October 1, 2014, there
could be significant disruptions in health care payments. The inability
of health plans to successfully process claims directly impacts the
timeliness of provider reimbursements for services rendered. Many
providers, especially small and rural providers, rely on the timeliness
of payments in order to continue to do business. A risk to a provider's
economic well-being is a risk to patient care.
In order to minimize industry disruption, it is important for the
Secretary to announce the new compliance dates as soon as possible.
Even with the extra few months this final rule affords, time is short.
If we were to engage in full notice and comment rulemaking, covered
entities would be left with uncertainty until a final rule could be
published, which would be unlikely to happen prior to October 1, 2014.
And even if the process could be expedited, a final rule would be
issued too close to October 1, 2014 to give most covered entities
sufficient time to comply with the requirements of the rule.
Accordingly, we find there is good cause to waive the normal notice and
comment rulemaking procedures, as they are impracticable and contrary
to the public interest.
IV. Collection of Information Requirements
This document does not impose information collection and
recordkeeping requirements. Consequently, it does not require a review
by the Office of Management and Budget under the authority of the
Paperwork Reduction Act of 1995.
V. Regulatory Impact Analysis
A. Statement of Need
As stated previously, section 212 of PAMA specifies that ``[t]he
Secretary of Health and Human Services may not, prior to October 1,
2015, adopt ICD-10 code sets as the standard for code sets under
section 1173(c) of the Social Security Act (42 U.S.C. 1320d-2(c)) and
section 162.1002 of title 45, Code of Federal Regulations.'' This final
rule establishes a new ICD-10 compliance date of October 1, 2015. It
also requires the continued use of ICD-9-CM through September 30, 2015.
B. Overall Impact
We have examined the impacts of this final rule as required by
Executive Order 12866 on Regulatory Planning and Review (September 30,
1993, as further amended), Executive Order 13563 on Improving
Regulation and Regulatory Review (January 18, 2011), section 202 of the
Unfunded Mandates Reform Act of 1995 (Pub. L. 104-4), Executive Order
13132 on Federalism (August 4, 1999), and the Congressional Review Act
(5 U.S.C. 804(2)).
Executive Orders 12866 and 13563 direct agencies to assess all
costs and benefits of available regulatory alternatives and, if
regulation is necessary, to select regulatory
[[Page 45131]]
approaches that maximize net benefits (including potential economic,
environmental, public health and safety effects, distributive impacts,
and equity). Section 3(f) of Executive Order 12866 defines a
``significant regulatory action'' as an action that is likely to result
in a rule: (1) Having an annual effect on the economy of $100 million
or more in any 1 year, or adversely and materially affecting a sector
of the economy, productivity, competition, jobs, the environment,
public health or safety, or state, local or tribal governments or
communities (also referred to as ``economically significant''); (2)
creating a serious inconsistency or otherwise interfering with an
action taken or planned by another agency; (3) materially altering the
budgetary impacts of entitlement grants, user fees, or loan programs or
the rights and obligations of recipients thereof; or (4) raising novel
legal or policy issues arising out of legal mandates, the President's
priorities, or the principles set forth in the Executive Order.
A regulatory impact analysis (RIA) must be prepared for major rules
with economically significant effects ($100 million in 1995 dollars or
more in any one year). We estimate that this rule is ``economically
significant'' as measured by the $100 million threshold, and hence also
a major rule under the Congressional Review Act. Accordingly, we have
prepared a Regulatory Impact Analysis (RIA) that presents the costs and
benefits of this rule.
In determining the costs of this final rule, we needed to
establish, as a baseline, what costs would likely be incurred absent
this final rule, and then compare this baseline to the costs of the
ICD-10 delay announced in this final rule. The costs estimated in this
RIA include costs to industry and government entities for an October 1,
2015 compliance date. For the RIA in this final rule we have also
relied largely on the estimates in the RIA of the 2012 ICD-10 Delay
final rule because that rule also estimated the cost of a 1-year delay
in the compliance date for ICD-10.
Section 202 of the Unfunded Mandates Reform Act of 1995 (UMRA) also
requires that agencies assess anticipated costs and benefits before
issuing any rule whose mandates require spending in any one year of
$100 million in 1995 dollars, updated annually for inflation. In 2014,
that threshold is approximately $141 million. This final rule contains
a mandate that would likely impose spending costs on the healthcare
industry of more than $141 million. Therefore, in this RIA we
illustrate the costs of the 1-year delay in compliance date for ICD-10.
Executive Order 13132 establishes certain requirements that an
agency must meet when it promulgates a final rule that imposes
substantial direct requirement costs on State and local governments,
preempts State laws, or otherwise has Federalism implications. We do
not anticipate that the 1-year delay in the compliance date for ICD-10
will have a significant impact on State and local governments, preempt
State laws, or otherwise have Federalism implications.
C. Anticipated Effects on Impacted Entities
ICD codes are used in nearly every sector of the health care
industry. All HIPAA covered entities will be affected by a delay in the
compliance date of ICD-10. Covered entities include all health plans,
health care clearinghouses, and health care providers that transmit
health information in electronic form in connection with a transaction
for which the Secretary has adopted a standard.
While covered entities are required to transition to ICD-10, many
other entities not covered by HIPAA also use ICD codes for a variety of
purposes because their operational and business needs often intersect
with those of covered entities. For practical and business purposes, we
expect these non-covered entities will voluntarily transition to ICD-
10. Entities that are not considered covered entities, but that may be
affected by the transition to ICD-10, include: Workers' compensation
programs and automobile and personal liability insurers, hardware and
software vendors for health care practice management systems and
electronic health record systems, researchers, public health
organizations, educational institutions, and coding entities.
D. Scope and Methodology of the Impact Analysis for ICD-10
This RIA estimates the costs of a delay of compliance with ICD-10.
In this RIA we are analyzing only the impact of a delay, not the impact
of ICD-10 implementation, which we addressed in the 2008 ICD-10
proposed rule (73 FR 49476) and the January 2009 ICD-10 final rule (74
FR 3328). For purposes of this analysis, we reference estimates made in
the RIA of the 2012 ICD-10 Delay final rule because it also delayed
compliance with ICD-10 by 1 year.
While we assume that a delay of the implementation of ICD-10 will
affect a broad range of health care providers, as illustrated in Table
1, we only examine the costs and benefits of a delay on two types of
health care providers: Hospitals and small providers. We do not analyze
the impact on other providers, including, but not limited to, nursing
and residential care facilities, dentists, or durable medical equipment
(DME) suppliers, though we understand that there is likely to be an
impact on most of these providers. As was the case for our impact
analysis in the 2008 ICD-10 proposed rule, there continues to be very
little publicly available data on the use of electronic data
interchange (EDI) among dentists, DME suppliers, nursing homes, and
residential care facilities. The lack of data for these types of health
care providers has been noted in other studies on administrative
simplification.\3\
---------------------------------------------------------------------------
\3\ ``Excess Billing and Insurance-Related Administrative
Costs,'' by James Kahn, in The Healthcare Imperative; Lowering Costs
and Improving Outcomes: Workshop Series Summary, edited by Pierre L.
Yong, Robert S. Saunders, and Leigh Anne Olsen, Institute of
Medicine of the National Academies, the National Academies Press,
Washington, DC: 2010.
---------------------------------------------------------------------------
We do not include an analysis of costs or benefits to health care
clearinghouses and transaction vendors in this RIA. Transaction vendors
are entities that process claims or payments for entities such as
health plans. Not all transaction vendors meet the HIPAA definition of
a health care clearinghouse, which constitute a subset of transaction
vendors. Payment vendors also would be a type of transaction vendor--a
transaction vendor that ``associates'' or ``re-associates'' health care
claim payments with the payments' remittance advice for either a health
plan or provider. For our purposes, transaction vendors do not include
developers or retailers of computer software or entities that are
involved in installing, programming or maintaining computer software.
However, we did not calculate costs and benefits to health care
clearinghouses and transaction vendors in this RIA because, as in our
previous impact analyses in the August 2008 ICD-10 proposed rule and
the 2012 ICD-10 Delay final rule, we assume that any associated costs
and benefits will be passed on to the health plans or providers and
will be included in the costs and benefits we apply to health plans and
providers.
Although self-insured group health plans meet the HIPAA definition
of ``health plan,'' we did not include them in this impact analysis.
While self-insured group health plans will be required to implement
ICD-10, we assume that, with a few exceptions, such plans do not send
or receive HIPAA electronic transactions because
[[Page 45132]]
most are not involved in the day-to-day activities of a health plan,
and outsource those services to third party administrators (TPAs) or
transaction vendors.
We do delineate a cost to TPAs in this RIA. Although TPAs do not
meet the definition of ``health plans,'' and therefore are not required
by HIPAA to use code sets such as ICD-10, as a practical matter they
will need to make the transition in order to continue to conduct
electronic transactions on behalf of self-insured group health plans.
The impact of a delay of the compliance date of ICD-10 on TPAs will be
similar to the commercial insurer cost/benefit impact profile as TPAs
serve a similar function and will have to implement and test their
systems in the same manner as health plans. Therefore, when we refer to
``commercial health plans'' in this RIA, we are including TPAs in the
category of ``small health plans'' in the RIA.
In the 2012 ICD-10 Delay final rule (77 FR 22991) and in this RIA,
we do not include the costs for software vendors, including software
vendors for practice management and EHR systems, as they ultimately
pass their costs to their clients.
E. Cost of a 1-Year Delay of Implementation of ICD-10 for Health Plans
1. Cost of a 1-Year Delay to Commercial Health Plans and TPAs
Health plans are a varied group in terms of size, and the cost of a
delay is calculated using a range that reflects this variance. In terms
of costs, commercial health plans are far along in their ICD-10
implementation and have devoted funds, resources, and staff to the
effort. When PAMA was enacted, the majority of commercial health plans
were in the external testing phase of their ICD-10 implementation
plans.\4\ A 1-year delay of ICD-10 compliance will allow entities more
time to thoroughly test, but the testing and the continued maintenance
of contracts and personnel required for the transition will be 1- year
longer than was budgeted.
---------------------------------------------------------------------------
\4\ Twenty of the top 25 health insurance companies indicated
that they were prepared to test with trading partners, according to
a scan of their Web sites. The top 25 health insurance companies
were identified by US News (https://health.usnews.com/health-news/health-insurance/articles/2013/12/16/top-health-insurance-companies).
---------------------------------------------------------------------------
Continued training, testing, and retention of personnel, and
contracts are expected to be the primary costs associated with a 1-year
delay for commercial health plans. Commercial health plans will perform
additional work in preparing their systems to process ICD-9 coded
claims for an additional year while also converting their systems to
process ICD-10 coded claims on and after October 1, 2015. We estimate
the costs of the delay for commercial health plans and third party
administrators to be between $547 million and $2,786 million.
2. Cost of a 1-Year Delay to Medicare
We believe many government health programs were prepared to be ICD-
10 compliant on October 1, 2014, and, like commercial payers, will
incur costs from a 1-year delay. As an example, components affected by
a 1-year delay at the Centers for Medicare & Medicaid Services (CMS),
in particular, Medicare Fee-for-Service (herein referred to as
Medicare), estimate that there will be additional costs. Like other
government payers, Medicare has programmed its claims processing
systems to accept and process ICD-10 codes on October 1, 2014. These
systems will have to be reconfigured to process ICD-9-CM-coded claims
for an additional year while also preparing to process ICD-10-coded
claims on and after October 1, 2015. Therefore, costs include
expenditures like extending contracts and reprogramming work for the
ICD-9-CM systems and ICD-10 systems while continuing to test ICD-10 in
the new 2015 systems environment. Other additional costs include an
increased need for outreach and education claims processing manual
updates, technical assistance, and training.
It was estimated in the 2012 final rule that a 1-year delay of ICD-
10 compliance would be reflected by additional work at an estimated
total cost of $5 to $10 million for the Medicare program. Because the
Medicare program was so far along in its ICD 10 implementation when
PAMA was enacted, we now estimate that the cost of a 1 year delay will
be $21 to $32 million for the Medicare program spread across FYs 2014
and 2015.
3. Cost of a 1-Year Delay to State Medicaid Agencies
State Medicaid Agencies (SMAs) completed a cost impact assessment
for a 1-year delay in April of 2014. SMAs face similar costs as
commercial health plans as a result of the 1-year delay of ICD-10. SMAs
will incur costs due to contractual obligations which may require
modifications, extensions, or procurements. Other costs to SMAs include
the need to test ICD-10 codes in the new 2015 systems environment,
which will be needed even by SMAs that have successfully tested to
date. SMA resources will need to be maintained at full pre-
implementation and go-live levels through 2015 in order to prepare for
the October 1, 2015 implementation. These will likely affect planning
and implementation of other IT initiatives for SMAs, potentially
resulting in additional costs and delays for those initiatives. SMAs
report the total cost for both state and federal of a 1-year delay for
all SMAs is $169 to $182 million.
F. Cost of a 1-Year Delay to Providers
1. Hospitals and Large Providers
We expect that many hospitals and large provider organizations have
already spent funds in preparation for the ICD-10 transition. As with
health plans, a delay of the compliance date will add to their costs
because large providers must maintain personnel staffing levels, make
significant system changes; renegotiate the contracts necessary to
extend preparations an extra year, and retest systems in the new 2015
systems environment. Likewise, large providers must maintain
technological resources for an extra year.
According to our estimates in the 2012 ICD-10 delay final rule, the
cost of a 1-year delay to hospitals and large physician practices will
be $409 million to $3.7 billion.
2. Small Providers
There are some surveys that estimate the associated costs for
providers transitioning to ICD-10, and we referenced some of these
studies in the 2012 ICD-10 Delay proposed rule (77 FR 22997). In that
proposed rule, we did not estimate the cost to small providers of the
1-year delay because these costs were negligible.
Given the lack of statistically valid data regarding the resources
small providers have expended, as well as their state of readiness for
an October 1, 2014 compliance date as compared to an October 1, 2015
compliance date, we do not estimate the cost or benefits to small
providers in this RIA. However, based on other relevant areas of the
health care industry, we assume that the change in compliance date will
negatively impact some percentage of small providers in terms of cost.
Nonetheless, the 1-year delay may also give relief to small providers
that were not prepared by affording them another year in which to
spread costs and resources.
G. Summary of Costs of a 1-Year Delay of the Compliance Date of ICD-10
Except for estimates of the impact on Medicare and State Medicaid
agencies, we are using the cost estimates from the 2012 ICD-10 Delay
final rule to
[[Page 45133]]
conclude that a 1-year delay of the ICD-10 compliance date would add a
range of 10 to 30 percent to the total cost that these entities have
already spent or budgeted for an October 1, 2014 implementation date,
for an additional cost to commercial entities of approximately $1
billion to $6.8 billion.
We summarize the range of low and high estimates of a 1-year delay
of the compliance date for ICD-10 in Table 1.
Table 1--Summary of Costs in 2015 of a 1-Year Delay in the Compliance Date of ICD-10 *
----------------------------------------------------------------------------------------------------------------
Low (in High (in Mean (average)
millions) millions) (in millions)
----------------------------------------------------------------------------------------------------------------
Cost to Commercial Health Plans........................... $547 $2,786 $1,667
Cost to Medicare.......................................... 21 32 27
Cost to State Medicaid Agencies........................... 169 182 176
Cost to Hospitals and Large Provider Organizations........ 422 3,849 2,136
-----------------------------------------------------
Total Costs........................................... 1,161 6,850 4,007
----------------------------------------------------------------------------------------------------------------
* In 2014 Dollars.
H. Considered Alternatives to a 1-Year Delay of the ICD-10 Compliance
Date
Section 212 of PAMA states that ``the Secretary of Health and Human
Services may not, prior to October 1, 2015, adopt ICD-10 code sets as
the standard for code sets under section 1173(c) of the Social Security
Act (42 U.S.C. 1320d-2(c)) and section 162.1002 of title 45, Code of
Federal Regulations.'' We interpret the statute as mandating a delay of
the compliance date of ICD-10, and permitting the Secretary discretion
to select the length of the delay, as long as implementation is
required no sooner than October 1, 2015. This final rule adopts a
compliance date of October 1, 2015.
We considered a number of delays of different durations before
establishing October 1, 2015 as the compliance date for ICD-10.
However, we concluded that a delay beyond 1 year would be significantly
more costly and have a damaging impact on industry. For example,
extending the delay beyond 1 year could render current ICD-10 system
updates and releases obsolete, which would diminish the investments
stakeholders have already made to prepare for the ICD-10 transition.
All segments of the health care industry have invested significant time
and resources in financing, training, and implementing necessary
changes to systems, workflow processes, and clinical documentation
practices. Stakeholders would need to restart their system preparation
and would not be able to leverage past system investments.
As estimated in the 2012 ICD-10 Delay final rule \5\ and repeated
in this final rule, a 1-year delay increases costs for covered entities
by a range of 10 to 30 percent. As indicated in the RIA in this final
rule, we estimate little to no benefit or cost savings in delays of
ICD-10 beyond the minimum 1-year delay required by PAMA. Although
industry readiness has not been studied, stakeholders representing a
significant majority of the industry have reported that they invested
significant time and resources and were prepared for the October 1,
2014 ICD-10 compliance date. A delay of longer than 1 year would slow
or stop progress towards ICD-10 implementation, delay the efficiencies
that can be achieved through ICD-10 implementation, and create wasteful
spending. Therefore, we believe that an October 1, 2015 compliance date
is the most appropriate alternative.
---------------------------------------------------------------------------
\5\ Administrative Simplification: Adoption of a Standard for a
Unique Health Plan Identifier; Addition to the National Provider
Identifier Requirements; and a Change to the Compliance Date for the
International Classification of Diseases, 10th Edition (ICD-10-CM
and ICD-10-PCS) Medical Data Code Sets; Final Rule. https://www.gpo.gov/fdsys/pkg/FR-2012-09-05/pdf/2012-21238.pdf pages 50-53.
---------------------------------------------------------------------------
I. Regulatory Flexibility Analysis: Impact on Small Providers of a
Delay in the Compliance Date of ICD-10
The Regulatory Flexibility Act (RFA) of 1980 (Pub. L. 96-354)
requires agencies to describe and analyze the impact of the final rule
on small entities unless the Secretary can certify that the regulation
will not have a significant impact on a substantial number of small
entities. According to the Small Business Administration's size
standards, a small entity is defined as follows according to health
care categories: Office of Physicians are defined as small entities if
they have revenues of $11 million or less; most other health care
providers (dentists, chiropractors, optometrists, mental health
specialists) are small entities if they have revenues of $7.5 million
or less; hospitals are small entities if they have revenues of $38.5
million or less. (For details, see the SBA's Web site at https://www.sba.gov/sites/default/files/Size_Standards_Table.pdf. Refer to
Sector 62--Health Care and Social Assistance).
As in the 2012 Delay final rule, we continue to assume for purposes
of the RFA, that all physician practices are small entities. We
conclude that a 1-year delay in implementation of the ICD-10 will
affect a ``substantial number'' of small entities. However, we assert
in this final rule, that the 1-year delay of the compliance date of
ICD-10 will be more beneficial to small entities than it will be
burdensome. The benefits are derived from the additional time that
small entities will have for ICD-10 implementation. Therefore, we
certify that the provisions in this final rule will not have a
significant economic impact on a substantial number of small entities.
J. Accounting Statement and Table
The total costs of a 1-year delay of the compliance date will
likely be incurred over a 12-month period. However, due to the range of
impacted entities, including educational institutions, those 12 months
may span different dates and different budget periods. Given the
diverse approaches to budgeting in the industry, there is no precise
way of calculating how much of the cost and cost avoidance falls
outside of the October 1, 2014 to October 1, 2015 timeframe. For
simplicity's sake, we calculate costs of a delay of the compliance date
for ICD-10 as occurring in calendar year 2015.
As required by OMB Circular A-4,\6\ Table 2 is an accounting
statement showing the classification of the expenditures associated
with the
[[Page 45134]]
provisions of this final rule. Table 2 provides our best estimates of
the costs and benefits associated with a 1-year delay of the compliance
date of ICD-10.
---------------------------------------------------------------------------
\6\ ``Circular A-4,'' September 17, 2003, Office of Management
and Budget (OMB), https://www.whitehouse.gov/omb/circulars_a004_a-4/.
Table 2--Accounting Statement: Classification of Estimated Expenditures for 1-Year Delay of ICD-10 Compliance
Date From FY 2014 to FY 2015
[In millions of dollars]
----------------------------------------------------------------------------------------------------------------
Minimum Maximum
Category Primary estimate estimate estimate Source citation (RIA,
(millions) (millions) (millions) preamble, etc.)
----------------------------------------------------------------------------------------------------------------
COSTS
----------------------------------------------------------------------------------------------------------------
Annualized Monetized costs:
7% Discount................. $4,007.0 $1,161.0 $6,850.0 RIA.
3% Discount................. 4,007.0 1,161.0 6,850.0 RIA.
----------------------------------------------------------------------------------------------------------------
List of Subjects in 45 CFR Part 162
Administrative practice and procedures, Electronic transactions,
Health facilities, Health insurance, Hospitals, Incorporation by
reference, Medicaid, Medicare, Reporting and recordkeeping
requirements.
For the reasons set forth in the preamble, the Department of Health
and Human Services amends 45 CFR Part 162 as follows:
PART 162--ADMINISTRATIVE REQUIREMENTS
0
1. The authority citation for part 162 continues to read as follows:
Authority: Secs. 1171 through 1180 of the Social Security Act
(42 U.S.C. 1320d-1320d-9), as added by sec. 262 of Pub. L. 104-191,
110 Stat 2021-2031, sec. 105 of Pub. L. 110-233, 122 Stat. 881-992,
and sec. 264 of Pub. L. 104-191, 110 Stat 2033-2034 (42 U.S.C.
1320d-2 (note)), secs. 1104 and 10109 of Pub. L. 111-148, 124 Stat
146-154 and 915-917.
Sec. 162.1002 [Amended]
0
2. Section 162.1002 is amended as follows:
0
A. In paragraph (b) introductory text by removing the date ``September
30, 2014'' and adding in its place the date ``September 30, 2015''.
0
B. In paragraph (c) introductory text by removing the date ``October 1,
2014'' and adding in its place the date ``October 1, 2015''.
Dated: July 17, 2014.
Marilyn Tavenner,
Administrator, Centers for Medicare & Medicaid Services.
Approved: July 25, 2014.
Sylvia M. Burwell,
Secretary, Department of Health and Human Services.
[FR Doc. 2014-18347 Filed 7-31-14; 4:15 pm]
BILLING CODE 4120-01-P